Talk on AI and Precision Medicine from Founder and Director of Scripps Research Translational Institute
Deep learning, a subtype of artificial intelligence (AI), has considerable transformative potential to promote accuracy, streamline workflow, synthesize data for both clinicians and patients, promote patient autonomy, and greatly enhance the patient-clinician relationship. To date, however, prospective validation studies are quite limited.
Dr. Eric Topol, M.D., will discuss how we need to confront such vital issues of how AI can unintentionally worsen inequities and discrimination. The goal, which may be considered counter-intuitive, is to use this technology to make medicine more human.
Eric Topol, M.D., founder and director of the Scripps Research Translational Institute, is widely known for his development of genomic and digital tools coupled with AI analytics geared to individualize medicine.
- Cancer Research Data Commons and Other NCI Infrastructures in Support of Data ScienceSeptember 19, 2021AttentiveChrome: Deep Learning for Predicting Gene Expression from Histone ModificationsSeptember 22, 2021“Le Grand et Le Petit”: Splicing Factors SF3B1 and SUGP1 and Their Cancer Mutations Leading to Aberrant Acceptor UsageSeptember 22, 2021The Future of Clinical Trial Data Sharing.... The Art of The PossibleSeptember 23, 2021Genomic Data Commons Single Cell RNA-Seq SupportSeptember 27, 2021Virtual Workshop on Next-Generation Sequencing and Radiomics: Resource Requirements for Acceleration of Clinical Applications Including AISeptember 29, 2021 - September 30, 2021